SUBSCRIBE
SUBSCRIBE
News   Business

Numira Biosciences, Inc. Eyes Break-Even As It Adds $5M To Series A

August 14, 2009 | 
1 min read
VentureWire -- Numira Biosciences Inc. has brought its Series A to $7.5 million in a round aimed at taking the specialty contract research company to break-even, the company told VentureWire....
Startups
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
SonomaBio Downsizes To Extend Runway
January 13, 2026
 · 
42 min read
 · 
BioSpace Editorial Staff
Johnson & Johnson's business center in Switzerland
Manufacturing
J&J To Add 500 Jobs at New Plant, Doubling Down on North Carolina
January 13, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Illustration showing woman starting down curved path with markers toward goal marked by flag
Gene therapy
After Mortality-Marred Year, Sarepta Looks Ahead to Catalyst-Rich 2026
January 13, 2026
 · 
2 min read
 · 
Tristan Manalac
Manhattan, New York USA - July 9, 2011: Pfizer letter sign on the building's Headquarters. Pfizer's is the largest pharmaceutical company in the world.
Business
JPM26: Pfizer Fast-Tracks Obesity Programs in Race Against Patent Cliff
January 13, 2026
 · 
3 min read
 · 
Nick Paul Taylor